Brief: Lifetech Scientific Says Entered Into Cooperation Framework Agreement With Sorrento Therapeutics
June 4 (Reuters) - Lifetech Scientific Corp 1302.HK :
* COMPANY HAS ENTERED INTO A COOPERATION FRAMEWORK AGREEMENT
WITH
SORRENTO THERAPEUTICS
* COOPERATION FRAMEWORK AGREEMENT WITH SORRENTO THERAPEUTICS
TO
FORM U.S. JOINT VENTURE SCINTILLA HEALTH
* UNDER AGREEMENT SORRENTO TO GRANT EXCLUSIVE LONG-TERM
LICENSE TO
SHENZHEN YUNMA IN ASIA & SCINTILLA HEALTH IN REGIONS OUTSIDE
ASIA
Source text for Eikon: ID:nHKS7gF4Kd
Further company coverage: 1302.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on LifeTech Scientific
See all newsBrief: Lifetech Scientific's Ics Elpis Admitted To Nmpa Special Examination On October 19, 2026
Brief: Lifetech Scientific Says Surechamtm Stent Graft Admitted To Nmpa Special Examination And Approval Procedure
Brief: Lifetech Scientific Expects Net Profit Attributable For Six Months Ended June 2026
Brief: Lifetech Scientific To Not Proceed With Major Deal
Brief: Lifetech Scientific To Buy 96.46% Of Starway Medical Technology